Global Chronic Liver Diseases and Cirrhosis Mortality by Country

In 2023, Romania leads in chronic liver diseases and cirrhosis mortality rates among men at 64.8 deaths per 100,000, followed closely by Estonia at 53.2. Notable trends over the past two years show varying degrees of increase, with Estonia experiencing a 9.56% rise and the United States 6.36%. In contrast, Slovenia and South Africa saw declines of -3.7% and -6.08%, respectively. Over the last five years, fluctuation in mortality rates suggests significant regional differences in medical infrastructure and preventive measures.

Looking ahead, further increases in high-risk countries such as Romania, Estonia, and Hungary could be anticipated due to limited healthcare interventions. Conversely, countries like Israel and South Africa may continue to reduce mortality rates with effective healthcare policies and awareness campaigns. Continuous monitoring is essential to address evolving health dynamics and disparities.

Top countries in Chronic Liver Diseases and Cirrhosis Mortality by Country

# 10 Countries Units (Male Deaths) Per Hundred Thousand Men Last Year YoY 5-years CAGR
1 1 Romania 64.8 2023 +0.31% +0.31% View data
2 2 Estonia 53.2 2023 +2.31% +9.56% View data
3 3 Slovakia 49 2023 +1.24% +0.62% View data
4 4 Bulgaria 45.2 2023 +1.35% +2.53% View data
5 5 Hungary 41.8 2023 -3.02% -2.93% View data
6 6 Lithuania 40.5 2023 +0.5% +5.15% View data
7 7 Mexico 39.5 2023 +0.25% +1.54% View data
8 8 Croatia 38.9 2023 +2.37% +0.44% View data
9 9 Finland 33.1 2023 +1.22% +3.55% View data
10 10 Poland 32.8 2023 +1.23% +3.14% View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease